Insiders / McFarlane Neil F.

McFarlane Neil F.

CIK 1681098personinsider
Companies
1
First seen
Feb 2, 2026
Last activity
Feb 10, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Zevra Therapeutics, Inc. · ZVRACEO387,225455,3508

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Zevra Therapeutics, Inc.Common Stock387,225Feb 9, 2026
Zevra Therapeutics, Inc.Stock Option (right to buy)Derivative250,000Jan 29, 2026
Zevra Therapeutics, Inc.Restricted Stock UnitDerivative75,000Feb 7, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 2, 2026SellZVRA
Zevra Therapeutics, Inc.
Common Stock
$853.4K-91K
-19.98%
364,350
0.61% of shares
medium
Feb 9, 2026SellZVRA
Zevra Therapeutics, Inc.
Common Stock
$125.2K-15K
-3.64%
387,225
0.65% of shares
medium
Feb 7, 2026ExerciseZVRA
Zevra Therapeutics, Inc.
Restricted Stock Unit
-38K
-33.33%
75,000
0.13% of shares
low
Feb 7, 2026ExerciseZVRA
Zevra Therapeutics, Inc.
Common Stock
+38K
+10.29%
401,850
0.68% of shares
low
Jan 31, 2026ExerciseZVRA
Zevra Therapeutics, Inc.
Restricted Stock Unit
-233K
-50.00%
233,333
0.39% of shares
low
Jan 29, 2026GrantZVRA
Zevra Therapeutics, Inc.
Stock Option (right to buy)
+250K
250,000
0.42% of shares
low
Jan 29, 2026GrantZVRA
Zevra Therapeutics, Inc.
Restricted Stock Unit
+125K
125,000
0.21% of shares
low
Jan 31, 2026ExerciseZVRA
Zevra Therapeutics, Inc.
Common Stock
+233K
+105.10%
455,350
0.77% of shares
low